Ostatní
Návod 
Myriad Genetics, Inc.
MYGN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.6B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-1
PS
1
Cena 1R
4-15
⌀ Cena
6.35
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
23-02-2026
Poslední dividenda
Profil
Myriad Genetics, Inc., společnost zabývající se genetickým testováním a přesným lékařstvím, vyvíjí a komercializuje genetické testy ve Spojených státech a mezinárodně. Společnost nabízí molekulární diagnostické testy pro použití v onkologii a pro aplikace v oblasti ženského a duševního zdraví. Poskytuje MyRisk Hereditary Cancer Test, sekvenční test DNA pro posouzení rizik pro dědičné nádory; BRACAnalysis CDx Germline Companion Diagnostic Test, sekvenční test DNA pro určení léčby pro pacienty s metastazujícím karcinomem prsu, ovariálním, metastazujícím pankreatickým nebo metastazujícím karcinomem prostaty se zhoubnými nebo podezřelými zhoubnými variantami BRCA zárodečné linie; a MyChoice CDx Companion Diagnostic Test, nádorový test, který určuje stav homologního rekombinačního deficitu u pacientů s karcinomem ovaria. Společnost dále nabízí Prolaris Prostate Cancer Prognostic Test, RNA expresní analýzu tumoru pro posouzení agresivity karcinomu prostaty; EndoPredict Prognostic Test karcinomu prsu, RNA expresivní test pro posouzení agresivity karcinomu prsu; Precise Tumor, řešení pro precizní onkologii; a Prequel Prenatal Screen, neinvazivní prenatální screeningový test prováděný pomocí mateřské krve pro zjištění závažných chromozomálních poruch u plodu. Kromě toho poskytuje Foresight Carrier Screen, prenatální test pro budoucí rodiče, aby posoudili riziko přenosu recesivního genetického stavu na své potomky, a GeneSight Psychotropní test medikace duševního zdraví, test genotypizace DNA, který má pomoci vybrat psychotropní léky pro pacienty trpící depresí, úzkostí, ADHD a dalšími duševními chorobami. Společnost Myriad Genetics, Inc. strategicky spolupracuje se společnostmi Illumina, Inc. a Intermountain Precision Genomics na nabídce služeb v oblasti testování zárodečných a somatických nádorů. Společnost byla založena v roce 1991 a sídlí v Salt Lake City v Utahu.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
2700
Založení
1995-10-06
Podobné společnosti
$ 16.17
+ $ 0.55
$ 27.52
+ $ 1.16
$ 18.11
+ $ 0.24
$ 5.36
+ $ 0.23
$ 5.18
+ $ 0.22
$ 3.05
+ $ 0.18
$ 8.94
- $ 0.01
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 824.5 | 824.5 | 837.6 | 753.2 | 678.4 | 690.6 | 851.1 | 772.6 | 771.4 | 753.8 | 723.1 | 778.2 | 613.2 | 496.0 | 402.1 | |
| Cost of Revenues | 247.9 | 247.9 | 252.2 | 236.2 | 202.0 | 197.6 | 201.0 | 177.2 | 171.2 | 157.3 | 147.4 | 109.2 | 79.6 | 64.7 | 46.7 | |
| Gross Profit | 576.6 | 576.6 | 585.4 | 517.0 | 476.4 | 493.0 | 650.1 | 595.4 | 600.2 | 596.5 | 575.7 | 669.0 | 533.5 | 431.3 | 355.4 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 209.8 | 205.7 | 213.1 | 195.9 | 210.6 | 213.3 | 211.5 | 202.2 | 196.6 | 191.9 | |
| Cost of Revenues | 63.0 | 61.9 | 61.3 | 61.7 | 59.7 | 63.5 | 64.4 | 64.6 | 61.6 | 57.6 | |
| Gross Profit | 146.8 | 143.8 | 151.8 | 134.2 | 150.9 | 149.8 | 147.1 | 137.6 | 135.0 | 134.3 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 88.7 | 85.4 | 81.9 | 85.9 | 70.8 | 74.4 | 70.6 | 75.5 | 67.5 | 53.7 | 42.6 | 27.8 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 572.9 | 514.7 | 599.8 | 555.5 | 467.1 | 476.4 | 359.1 | 366.0 | 327.1 | 251.8 | 208.4 | 169.8 | |
| Depreciation & Amortization | -14.4 | -14.4 | 61.2 | 61.9 | 55.9 | 62.8 | 73.0 | 54.4 | 48.3 | 26.7 | 25.0 | 13.8 | 8.9 | 9.1 | 7.2 | |
| Total Operating Expenses | 838.1 | 715.9 | 708.9 | 774.4 | 600.1 | 681.7 | 641.4 | 537.9 | 550.8 | 429.7 | 441.5 | 394.6 | 305.5 | 251.0 | 197.6 | |
| Operating Income | -261.5 | -139.3 | -123.5 | -257.4 | -123.7 | -48.7 | 7.6 | 118.7 | 49.4 | 166.8 | 134.2 | 274.4 | 228.0 | 180.3 | 157.8 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.0 | 24.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 32.6 | 170.4 | ||
| Depreciation & Amortization | -55.5 | 12.6 | 14.1 | 14.4 | 14.8 | 15.6 | 15.1 | 15.7 | 15.1 | 14.1 | ||
| Total Operating Expenses | 26.8 | 167.1 | 481.0 | 163.2 | 189.9 | 169.8 | 183.6 | 165.5 | 166.4 | 194.4 | ||
| Operating Income | 120.0 | -23.3 | -329.2 | -29.0 | -39.0 | -20.0 | -36.5 | -27.9 | -31.4 | -60.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.8 | 1.8 | 1.7 | 2.5 | 2.6 | 0.7 | 3.2 | 1.8 | 1.2 | 0.9 | 0.4 | 5.4 | 5.5 | 4.6 | 2.2 | |
| Interest Expense | 10.5 | 12.1 | 2.8 | 2.9 | 3.2 | 6.6 | 12.0 | 3.2 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -4.7 | -255.8 | 0.0 | -4.8 | -16.9 | -8.4 | 0.1 | 60.8 | -1.7 | 1.2 | 0.3 | -2.0 | -0.2 | -0.4 | -0.4 | |
| IBT | -395.1 | -395.1 | -123.5 | -262.2 | -140.6 | -57.1 | 0.2 | 116.9 | 42.9 | 168.9 | 134.9 | 277.9 | 233.3 | 184.5 | 159.7 | |
| Income Tax Expense | -29.2 | -29.2 | 3.8 | 1.1 | -28.6 | -29.9 | -4.4 | -13.9 | 21.3 | 43.6 | 54.7 | 101.6 | 86.1 | 72.4 | 58.9 | |
| Net Income | -365.9 | -365.9 | -127.3 | -263.3 | -112.0 | -27.2 | 4.6 | 131.0 | 21.8 | 125.3 | 80.2 | 176.2 | 147.1 | 112.2 | 100.7 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.8 | 0.5 | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 | 0.6 | 0.7 | 0.6 | ||
| Interest Expense | 4.4 | 3.8 | 1.5 | 0.8 | 0.7 | 0.8 | 0.8 | 0.5 | 0.9 | 1.0 | ||
| Other Expense | 0.0 | -2.9 | -1.4 | -0.4 | -0.1 | -1.2 | -0.7 | 2.0 | -0.9 | -0.7 | ||
| IBT | -8.9 | -26.2 | -330.6 | -29.4 | -39.1 | -21.2 | -37.2 | -25.9 | -32.3 | -61.2 | ||
| Income Tax Expense | -1.0 | 1.2 | -0.1 | -29.3 | 3.4 | 0.9 | -0.5 | 0.1 | -1.1 | 0.1 | ||
| Net Income | -7.9 | -27.4 | -330.5 | -0.1 | -42.5 | -22.1 | -36.7 | -26.0 | -31.2 | -61.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-3.18 | $-1.39 | $-0.35 | $0.06 | $1.89 | $0.32 | $1.79 | $1.12 | $2.33 | $1.82 | $1.33 | $1.12 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-3.18 | $-1.39 | $-0.35 | $0.06 | $1.82 | $0.32 | $1.71 | $1.08 | $2.25 | $1.77 | $1.30 | $1.10 | |
| Shares Outstanding | 93.3 | 93.3 | 90.6 | 82.8 | 80.6 | 78.0 | 73.5 | 69.4 | 68.3 | 70.0 | 71.3 | 75.7 | 80.9 | 84.6 | 89.8 | |
| Diluted Shares Outstanding | 93.3 | 93.3 | 90.6 | 82.8 | 80.6 | 78.0 | 76.0 | 72.0 | 68.8 | 73.4 | 74.5 | 78.2 | 83.3 | 86.5 | 91.7 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.36 | $-0.75 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.36 | $-0.75 | ||
| Shares Outstanding | 93.3 | 93.1 | 92.5 | 91.4 | 91.1 | 90.9 | 90.6 | 89.9 | 86.1 | 81.7 | ||
| Diluted Shares Outstanding | 93.3 | 93.1 | 92.5 | 91.4 | 91.1 | 90.9 | 90.6 | 89.9 | 86.1 | 81.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 76.0 | 102.4 | 132.1 | 56.9 | 258.4 | 93.2 | 110.9 | 102.4 | 68.5 | 64.1 | 64.8 | 104.1 | 86.4 | 52.7 | |
| Short Term Investments | 10.3 | 0.0 | 8.8 | 58.0 | 81.4 | 43.7 | 69.7 | 48.3 | 90.5 | 80.7 | 121.6 | 268.2 | 254.2 | 293.8 | |
| Total Cash & ST Investments | 86.3 | 102.4 | 140.9 | 114.9 | 339.8 | 136.9 | 180.6 | 150.7 | 159.0 | 144.8 | 270.6 | 531.1 | 454.2 | 346.5 | |
| Accounts Receivable | 115.2 | 121.2 | 114.3 | 101.6 | 91.3 | 138.6 | 102.1 | 111.3 | 95.0 | 87.7 | 98.7 | 97.7 | 63.1 | 50.3 | |
| Inventory | 25.1 | 27.5 | 22.0 | 20.1 | 15.3 | 31.4 | 34.3 | 42.2 | 38.3 | 25.1 | 23.9 | 5.0 | 11.6 | 5.7 | |
| Other Current Assets | 21.3 | 46.9 | 36.4 | 20.4 | 38.4 | 41.7 | 9.4 | 12.9 | 22.2 | 26.0 | 27.0 | 9.0 | 7.3 | 417.9 | |
| Total Current Assets | 265.4 | 298.0 | 313.6 | 274.6 | 484.8 | 348.6 | 326.4 | 317.1 | 314.5 | 283.6 | 400.1 | 634.7 | 530.6 | 479.3 |
| Current Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 74.4 | 91.8 | 102.4 | 99.9 | 92.4 | 96.9 | 132.1 | 76.0 | 102.8 | 53.6 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 4.9 | 7.4 | 8.8 | 10.3 | 18.8 | 25.1 | |
| Total Cash & ST Investments | 74.4 | 91.8 | 102.4 | 99.9 | 97.3 | 104.3 | 140.9 | 86.3 | 121.6 | 78.7 | |
| Accounts Receivable | 137.0 | 120.4 | 121.2 | 125.7 | 117.8 | 118.1 | 114.3 | 115.2 | 111.7 | 119.1 | |
| Inventory | 28.7 | 28.3 | 27.5 | 26.2 | 26.1 | 24.6 | 22.0 | 25.1 | 22.5 | 21.8 | |
| Other Current Assets | 44.2 | 46.7 | 46.9 | 41.4 | 50.4 | 43.3 | 36.4 | 21.3 | 20.8 | 24.4 | |
| Total Current Assets | 284.3 | 287.2 | 298.0 | 293.2 | 291.6 | 290.3 | 313.6 | 265.4 | 294.3 | 261.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 224.7 | 172.4 | 180.6 | 187.3 | 125.3 | 57.3 | 43.2 | 51.1 | 58.3 | 67.2 | 34.6 | 27.6 | 24.2 | 23.1 | |
| Goodwill | 286.6 | 286.3 | 287.4 | 286.8 | 239.2 | 417.2 | 318.6 | 316.1 | 195.3 | 177.2 | 169.2 | 56.9 | 56.9 | 56.1 | |
| Intangible Assets | 356.6 | 262.4 | 349.5 | 379.7 | 404.1 | 684.7 | 455.2 | 491.6 | 227.5 | 192.6 | 205.3 | 13.3 | 15.7 | 16.7 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 54.8 | 59.0 | 54.9 | 30.7 | 48.5 | 79.9 | 40.6 | 84.1 | 158.7 | 113.7 | 70.9 | |
| Other Long-Term Assets | 15.8 | 8.5 | 15.4 | 15.5 | 8.3 | 0.0 | 0.0 | 0.0 | 5.0 | 5.0 | -79.1 | -124.1 | -86.7 | -70.9 | |
| Total Long-Term Assets | 883.7 | 729.6 | 832.9 | 924.1 | 835.9 | 1,214.1 | 847.7 | 907.3 | 566.0 | 482.6 | 423.7 | 169.1 | 160.0 | 131.5 | |
| Total Assets | 1,149.1 | 1,027.6 | 1,146.5 | 1,198.7 | 1,320.7 | 1,562.7 | 1,174.1 | 1,224.4 | 880.5 | 766.2 | 823.8 | 803.8 | 690.6 | 610.8 |
| Long-Term Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 164.2 | 167.4 | 172.4 | 172.8 | 172.8 | 177.4 | 180.6 | 224.7 | 218.6 | 203.3 | |
| Goodwill | 51.6 | 286.3 | 286.3 | 286.3 | 286.3 | 287.0 | 287.4 | 286.6 | 287.2 | 287.1 | |
| Intangible Assets | 169.5 | 257.5 | 262.4 | 312.5 | 319.5 | 340.9 | 349.5 | 356.6 | 358.8 | 369.4 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.2 | 30.4 | |
| Other Long-Term Assets | 7.1 | 7.7 | 8.5 | 16.5 | 14.9 | 14.9 | 15.4 | 15.8 | 22.1 | 17.5 | |
| Total Long-Term Assets | 392.4 | 718.9 | 729.6 | 788.1 | 793.5 | 820.2 | 832.9 | 883.7 | 892.9 | 907.7 | |
| Total Assets | 677.3 | 1,006.1 | 1,027.6 | 1,081.3 | 1,085.1 | 1,110.5 | 1,146.5 | 1,149.1 | 1,187.2 | 1,169.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 33.9 | 32.3 | 25.8 | 28.8 | 29.6 | 33.3 | 26.0 | 22.0 | 21.1 | 21.1 | 23.1 | 18.1 | 10.1 | 11.4 | |
| Short-Term Debt | 17.8 | 12.8 | 16.2 | 14.1 | 13.0 | 78.9 | 68.3 | 65.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.6 | |
| Other Current Liabilities | 157.6 | 113.9 | 109.3 | 93.7 | 156.5 | 3.4 | 5.3 | 127.3 | 49.5 | 46.1 | 56.4 | 44.3 | 32.8 | 21.6 | |
| Current Liabilities | 209.3 | 164.1 | 155.9 | 137.2 | 204.3 | 117.8 | 102.2 | 217.5 | 72.3 | 68.7 | 80.6 | 64.5 | 45.0 | 44.0 |
| Current Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 30.9 | 28.1 | 32.3 | 29.6 | 9.0 | 33.1 | 25.8 | 33.9 | 39.8 | 36.5 | |
| Short-Term Debt | 68.4 | 10.9 | 12.8 | 13.5 | 13.3 | 13.8 | 16.2 | 17.8 | 17.0 | 15.1 | |
| Other Current Liabilities | 95.5 | 103.1 | 113.9 | 107.0 | 122.0 | 93.1 | 109.3 | 123.7 | 119.9 | 50.5 | |
| Current Liabilities | 199.9 | 151.1 | 164.1 | 154.3 | 148.9 | 146.1 | 155.9 | 209.3 | 221.1 | 143.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 183.6 | 127.5 | 135.9 | 130.9 | 79.3 | 233.5 | 9.3 | 99.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 162.9 | 100.7 | 113.6 | 145.0 | 92.3 | 70.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 2.7 | 0.0 | 0.0 | 3.5 | 35.8 | 82.6 | 57.3 | 84.4 | 17.9 | 0.2 | 24.2 | 10.7 | 10.0 | 9.6 | |
| Total Liabilities | 465.7 | 326.5 | 363.3 | 312.9 | 352.9 | 473.8 | 209.2 | 446.6 | 132.4 | 104.1 | 104.8 | 75.2 | 55.0 | 44.0 |
| Long-Term Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 86.2 | 146.7 | 127.5 | 129.6 | 130.0 | 133.0 | 135.9 | 183.6 | 186.8 | 146.5 | |
| Capital Leases | 95.2 | 98.3 | 100.7 | 104.1 | 104.5 | 108.1 | 113.6 | 162.9 | 165.4 | 161.6 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.7 | 3.7 | 4.1 | |
| Total Liabilities | 289.2 | 301.2 | 326.5 | 349.6 | 344.6 | 350.5 | 363.3 | 465.7 | 452.0 | 334.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.8 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 0.9 | |
| Retained Earnings | -598.3 | -756.8 | -629.5 | -366.2 | -254.2 | 25.6 | 52.8 | -68.4 | -73.2 | -77.0 | 2.0 | 30.9 | -12.7 | -38.6 | |
| Comprehensive Income | -5.3 | -0.8 | -3.7 | -8.9 | -5.1 | -5.4 | -4.0 | -5.5 | -9.5 | -7.0 | -1.5 | -0.4 | -0.2 | 0.2 | |
| Total Common Equity | 683.4 | 701.1 | 783.2 | 885.8 | 967.8 | 1,088.9 | 964.9 | 778.2 | 748.1 | 662.1 | 719.0 | 728.6 | 635.7 | 566.8 |
| Total Common Equity | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | |
| Retained Earnings | -1,087.4 | -756.9 | -756.8 | -714.3 | -692.2 | -655.5 | -629.5 | -598.3 | -537.0 | -420.9 | |
| Comprehensive Income | -0.1 | -0.6 | -0.8 | -0.1 | -4.0 | -4.2 | -3.7 | -5.3 | -5.4 | -7.4 | |
| Total Common Equity | 388.1 | 704.9 | 701.1 | 731.7 | 740.5 | 760.0 | 783.2 | 683.4 | 735.2 | 835.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 201.4 | 140.3 | 152.1 | 145.0 | 92.3 | 233.5 | 9.3 | 99.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 683.4 | 701.1 | 783.2 | 885.8 | 967.8 | 1,088.9 | 964.9 | 777.8 | 748.1 | 662.1 | 719.0 | 728.6 | 635.7 | 566.8 |
| Other | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 388.1 | 704.9 | 701.1 | 731.7 | 740.5 | 760.0 | 783.2 | 683.4 | 735.2 | 835.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -274.4 | 0.0 | -127.3 | -263.3 | -112.0 | -27.2 | 4.6 | 131.0 | 21.8 | 125.3 | 80.2 | 176.2 | 147.1 | 112.2 | 100.7 | |
| Depreciation & Amortization | 60.5 | 0.0 | 61.2 | 61.9 | 52.7 | 62.8 | 73.0 | 54.4 | 48.3 | 26.7 | 25.0 | 13.8 | 8.9 | 9.1 | 7.2 | |
| Stock-Based Compensation | 38.5 | 0.0 | 49.8 | 40.7 | 38.1 | 36.3 | 33.5 | 27.1 | 29.9 | 31.6 | 45.7 | 27.1 | 26.6 | 26.3 | 25.1 | |
| Change Working Capital | 73.0 | 0.0 | -54.4 | 27.0 | -101.5 | 120.4 | -37.1 | -21.6 | -36.6 | -65.4 | -40.7 | -60.0 | -41.0 | -28.8 | 38.5 | |
| Change In Accounts Receivable | -11.2 | 0.0 | -8.7 | 3.8 | -10.3 | -8.8 | -18.2 | -39.2 | -41.4 | -39.2 | -34.4 | -24.4 | -67.2 | -34.9 | -15.0 | |
| Change In Accounts Payable | -0.2 | 0.0 | 4.7 | -3.7 | -3.5 | 9.2 | 1.1 | 4.0 | -3.0 | -11.4 | -3.1 | -1.5 | 8.0 | -1.2 | 0.3 | |
| Change In Inventories | -3.5 | 0.0 | -6.2 | -1.8 | -2.9 | 1.6 | 8.0 | 7.9 | -1.2 | -14.6 | -0.8 | -15.8 | 6.6 | -3.4 | 0.2 | |
| Other Non-cash Items | 47.4 | 1.8 | 62.3 | 23.4 | 48.3 | -139.4 | -3.4 | -51.3 | 40.3 | 32.4 | 28.6 | 25.6 | 24.1 | -11.1 | -81.2 | |
| Cash from Operations | -63.9 | 0.0 | 0.0 | -110.9 | -106.3 | 18.2 | 83.7 | 115.9 | 106.2 | 166.3 | 140.5 | 190.2 | 173.9 | 141.8 | 130.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.0 | -27.4 | -330.5 | -0.1 | -42.5 | -22.1 | -36.7 | -26.0 | -31.2 | -61.3 | |
| Depreciation & Amortization | 0.0 | 12.6 | 14.1 | 14.4 | 14.8 | 15.6 | 15.1 | 15.7 | 15.1 | 14.1 | |
| Stock-Based Compensation | 0.0 | 12.2 | 10.7 | 9.5 | 10.9 | 12.4 | 14.5 | 12.0 | 10.4 | 11.6 | |
| Change Working Capital | 0.0 | 21.4 | -27.0 | -12.1 | -24.2 | -7.3 | -2.3 | -20.6 | -41.3 | 9.8 | |
| Change In Accounts Receivable | 0.0 | 19.0 | -16.2 | 0.8 | 4.0 | -8.2 | -0.6 | -3.9 | 1.2 | -3.6 | |
| Change In Accounts Payable | 0.0 | -0.8 | 3.6 | 0.0 | -1.1 | -3.6 | 3.3 | 6.1 | -5.9 | -8.5 | |
| Change In Inventories | 0.0 | -2.9 | -0.3 | -0.9 | -1.3 | 0.0 | -3.1 | -1.8 | 3.2 | -2.7 | |
| Other Non-cash Items | 10.6 | 2.3 | 319.3 | 3.3 | 46.1 | 3.2 | 13.9 | -0.9 | -6.0 | 4.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -54.7 | -22.1 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -74.4 | 0.0 | -29.7 | -73.3 | -45.3 | -18.0 | -8.6 | -8.4 | -6.1 | -5.0 | -23.9 | -14.3 | -11.4 | -10.2 | -5.8 | |
| Acquisitions | -57.2 | 0.0 | 8.8 | 0.0 | -57.2 | 379.1 | -278.5 | 8.4 | -216.1 | -37.0 | -20.1 | -223.5 | -5.0 | -0.8 | -79.4 | |
| Investments | -4.4 | 0.0 | 0.0 | 0.0 | -103.2 | -147.8 | -78.5 | -80.9 | -87.5 | -164.5 | -80.7 | -161.8 | -443.8 | -396.1 | -425.2 | |
| Sales of Investment | 144.3 | 0.0 | 9.0 | 105.2 | 128.2 | 61.1 | 79.2 | 77.7 | 163.4 | 115.1 | 165.6 | 381.9 | 384.6 | 385.2 | 456.1 | |
| Other Investing Activities | -6.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -17.1 | -0.1 | |
| Cash from Investing | 8.3 | 0.0 | 0.0 | 31.9 | -77.5 | 274.4 | -286.4 | -11.6 | -146.3 | -91.4 | 40.9 | -17.7 | -75.6 | -38.9 | -54.4 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | -6.2 | -6.9 | -8.3 | -5.9 | -6.3 | -8.9 | -8.6 | -13.5 | -17.5 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.0 | 2.5 | 1.5 | 1.5 | 15.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -12.0 | -2.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 31.0 | 0.0 | 0.0 | 39.8 | 0.0 | -226.4 | -115.0 | -143.0 | -305.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 100.1 | 140.3 | -11.8 | 46.9 | 52.7 | 318.7 | 348.5 | 53.2 | 404.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 3.0 | 0.0 | 0.0 | 117.6 | 6.3 | 91.8 | 8.7 | 36.9 | 6.0 | 0.0 | 30.0 | 0.0 | 0.0 | 0.0 | 25.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -50.0 | 0.0 | -31.6 | -162.6 | -210.7 | -287.7 | -146.3 | -128.5 | -200.5 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -340.0 | 0.0 | -403.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -5.1 | 0.0 | 0.0 | -4.5 | -14.3 | -16.0 | 678.6 | 11.1 | 805.4 | 94.3 | 3.4 | 75.9 | 65.7 | 59.2 | 58.8 | |
| Cash from Financing | 28.9 | 0.0 | 0.0 | 152.9 | -8.0 | -150.6 | 182.3 | -95.0 | 71.8 | -68.3 | -177.3 | -211.8 | -80.6 | -69.2 | -116.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.1 | 0.0 | |
| Debt Issued | 0.0 | 154.6 | -3.0 | 17.3 | -2.8 | -0.2 | -3.5 | -5.3 | -42.2 | -2.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 114.8 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 121.9 | -2.5 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -25.7 | 39.4 | -29.0 | 74.5 | -192.4 | 141.4 | -17.7 | 8.5 | 33.9 | 4.4 | -0.7 | -39.3 | 17.7 | 33.7 | -40.2 | |
| Closing Cash Balance | 85.0 | 151.3 | 111.9 | 140.9 | 66.4 | 258.4 | 93.2 | 110.9 | 102.4 | 68.5 | 64.1 | 64.8 | 104.1 | 86.4 | 52.7 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -3.5 | 71.1 | -17.3 | -10.9 | 2.1 | 8.6 | -4.4 | -35.3 | 55.9 | -27.7 | |
| Closing Cash Balance | 151.3 | 154.8 | 83.7 | 101.0 | 111.9 | 109.8 | 101.2 | 105.6 | 140.9 | 85.0 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -138.3 | 1.8 | -38.4 | -184.2 | -151.6 | 0.2 | 75.1 | 107.5 | 100.1 | 161.3 | 116.6 | 175.9 | 162.5 | 131.7 | 125.0 | |
| Real Free Cash Flow | -176.8 | 1.8 | -88.2 | -224.9 | -189.7 | -36.1 | 41.6 | 80.4 | 70.2 | 129.7 | 70.9 | 148.9 | 135.9 | 105.4 | 99.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 10.6 | 18.3 | -20.5 | -24.6 | 0.7 | -5.6 | -6.3 | -27.2 | -68.2 | -39.6 | |
| Real Free Cash Flow | 10.6 | 6.1 | -31.2 | -34.1 | -10.2 | -18.0 | -20.8 | -39.2 | -78.6 | -51.2 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -1.2 | 12.2 | 63 |
| P/S | 0.5 | 3.3 | 57.8 |
| P/B | 1.1 | 2.6 | 29.8 |
| P/FCF | -8.7 | 12.6 | 549.4 |
| Market cap | $0.6 | $1.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 7.3 % | 0 % |
| Debt to Income | -42.3 % | 43.7 % | 0 % |
| Debt to Free cash flow | -318.1 % | 7.4 % | 0 % |
| Interest expense percentage | -4 % | 1.2 % | 2.9 % |
| Current ratio | 1.4 | 5.8 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -94.3 % | 3.5 % | 0 % |
| ROA | -54 % | 4.6 % | 0 % |
| CapEx to Revenue | 2.6 % | 2.3 % | 0 % |
| RaD to Revenue | 0 % | 9.4 % | 0 % |
| ROEM | 305,370.4 | 231980.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 69.9 % | 78.7 % | 47.8 % |
| Operating margin | -31.7 % | 7.5 % | 28 % |
| Net margin | -44.4 % | 5.2 % | 19.8 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.2 % | 0 % |
| Dividend payout percentage | 0 % | 14.6 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 93.3 mil | 76.3 mil |
| Employee count | 2.7 tis | 1.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
